Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Biotech Vertex Pharma Has a Blockbuster Drug That Rivals Envy
06:48pm, Thursday, 10'th Mar 2022 The Street
A gene therapy by Vertex Pharma has turned out to be a money spinner for the company.
Vertex Pharmaceuticals, Inc. (VRTX) Presents at Cowen Health Care Broker Conference Call - (Transcript)
11:14pm, Tuesday, 08'th Mar 2022 Seeking AlphaVertex Pharmaceuticals, Inc. (VRTX) Presents at Cowen Health Care Broker Conference Call - (Transcript)
06:14pm, Tuesday, 08'th Mar 2022
Vertex Pharmaceuticals, Inc. (VRTX) Presents at Cowen Health Care Broker Conference Call - (Transcript)
3 Biotech Stocks That Can Make You Richer in March (and Beyond)
07:04am, Sunday, 06'th Mar 2022
These biotechs have promising near-term and long-term prospects.
UnitedHealth, Vertex Lead Five Stocks Looking Healthy In A Weak Market
01:00pm, Saturday, 05'th Mar 2022 Investor''s Business Daily
UnitedHealth and Vertex Pharmaceuticals are among five medical stocks with healthy action in a weak market.
1 Healthcare Stock That Could Fly Higher After a Strong Q4
11:23am, Saturday, 05'th Mar 2022
This pharmaceutical company is growing revenue and profits from drugs it doesn't market or sell.
What's Next For Vertex Pharma, The World's Largest Cystic Fibrosis Drugmaker?
08:48pm, Friday, 04'th Mar 2022
For more than a decade, the world has known Vertex Pharmaceuticals as the cystic fibrosis biotech. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock
Why IBD Stock Of The Day Vertex Pharmaceuticals Is Outperforming Its Biotech Brethren
06:13pm, Friday, 04'th Mar 2022 Investor''s Business Daily
Vertex stock is the IBD Stock Of The Day after bounding off its key moving averages as excitement grows for its non-cystic fibrosis plans.
Here’s a Great Reason to Invest in Vertex Pharmaceuticals (VRTX)
02:19pm, Thursday, 03'rd Mar 2022 Insider Monkey
Harding Loevner, an investment management firm, published its “Global Equity Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
2 Stocks to Buy No Matter What Happens in March
10:45am, Tuesday, 01'st Mar 2022
Keep your eyes on the prize.
4 Stocks With a History of Operating Income Margin Growth
12:32pm, Sunday, 27'th Feb 2022
When the operating income margin continues to grow, it means a company is becoming more efficient in generating profits from its operating activities.
Should Value Investors Pick Vertex Pharmaceuticals (VRTX) Stock?
10:46am, Monday, 21'st Feb 2022
Let's see if Vertex Pharmaceuticals Incorporated (VRTX) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top pic
Vertex Could Be a Seller or Buyer in Biotech M&A
10:05am, Wednesday, 16'th Feb 2022
As measured by its current market cap, Vertex Pharmaceuticals ( VRTX , Financial) would be the most expensive among the 10 companies identified by Fierce Biotech as the top M&A targets, with Adaptimmu
VRTX vs. TECH: Which Stock Should Value Investors Buy Now?
01:06pm, Tuesday, 15'th Feb 2022
VRTX vs. TECH: Which Stock Is the Better Value Option?
Will the Rally of These 5 Big Drugmakers Continue in 2022?
12:19pm, Friday, 11'th Feb 2022
Here we discuss five big pharma/biotech companies - SNY, ABBV, BMY, AMGN and VRTX - with the potential to drive investors' wealth higher in 2022 on the back of strong fundamentals.
